02 October 2024
02 October 2024
The primary endpoint results from the trial are expected by the end of the year and will be used to support an FDA approval for the OCT B-Series device.
One of the key challenges in stroke care is the limited window available for treatment once symptoms arise.
The news of a successful Vantage 3D implant surgery is sure to show Exactech in a positive light and as the demand for ankle replacements is growing rapidly.
The app will be introduced in two phased rollouts, with patients able to manage their own appointments or message clinicians through the platform.
Synchron’s study is the first approved by the FDA to test a permanently implanted BCI.
The Mammomat B.brilliant platform is Siemens’ first completely redesigned mammography system in over a decade.
One of the most exciting recent developments in AI-based healthcare is the collaboration between AvaSure, Oracle, and NVIDIA.
Researchers found that the company’s CheekAge swab test is able to significantly simplify the collection of methylation data through cheek cells.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
